The global mobile gamma cameras market value is poised for growth, driven by the increasing demand for portable diagnostic imaging equipment in hospitals, imaging centres and ambulatory settings. Mobile gamma cameras provide functional imaging of organs (such as cardiac, renal, brain, thyroid and breast) with flexibility to be used bedside or in situations where traditional fixed gamma cameras are less accessible.
Key market drivers include rising incidence of chronic diseases (especially cardiovascular disease and cancer), technological advancements in portable imaging systems (better resolution, lighter weight, faster acquisition), and the need for cost-efficient diagnostics in constrained clinical settings.

Download Sample PDF :

Market Segmentation

• By Product Type: Single-head mobile gamma cameras; Double/dual-head mobile gamma cameras; Triple-head mobile gamma cameras; Hand-held mobile gamma cameras.
  
  
• By Indication/Application: Cardiac imaging; Breast imaging; Hepatobiliary imaging; Gastrointestinal imaging; Renal imaging; Brain imaging; Other applications.
  
  
• By End-User: Hospitals; Ambulatory surgical centres/imaging centres; Cancer research institutes; Specialty clinics.
  
  
• By Region: North America; Europe; Asia-Pacific; Latin America; Middle East & Africa.
  
  

Regional Insights

• North America: A dominant region—driven by established healthcare infrastructure, high adoption of advanced imaging devices, high incidence of chronic disease and readiness to invest in portable diagnostics.
  
  
• Europe: Significant share of market, with strong imaging centre networks and moderate growth in portable devices adoption.
  
  
• Asia-Pacific: Expected to be one of the fastest-growing regions as healthcare access expands, imaging equipment investments rise, and portable solutions become more relevant in less-developed geographies.
  
  
• Latin America & Middle East & Africa: Emerging opportunities, though growth may be somewhat slowed by limited budgets, infrastructure constraints and slower uptake of premium imaging technologies.
  
  

Key Market Drivers

• Increasing burden of chronic and complex diseases: Conditions such as cardiovascular disease, cancer and renal disorders require functional imaging—boosting demand for gamma camera systems, including mobile variants.
  
  
• Need for portability, flexibility & point-of-care imaging: Mobile gamma cameras enable imaging at bedside or in non-traditional settings (e.g., operating theatres, outpatient centres), improving workflow and patient convenience.
  
  
• Technological advancements and improved performance: Advances in detector technology, image resolution, acquisition speed and device portability support growth of mobile gamma camera adoption.
  
  
• Expansion of healthcare infrastructure in emerging markets: Growth of hospitals, imaging centres, investment in diagnostic equipment in Asia-Pacific and other regions enhances addressable market.
  
  

Market Challenges

• High cost of advanced imaging equipment: Mobile gamma cameras remain a significant investment; hospitals/clinics in cost-sensitive markets may delay adoption.
  
  
• Regulatory, reimbursement and clinical-workflow barriers: Integration of mobile gamma cameras, demonstration of clinical value and reimbursement acceptance may take time.
  
  
• Competition from other imaging modalities & fixed systems: Some facilities may continue to rely on fixed gamma/SPECT/CT systems or alternative imaging technologies rather than upgrade to mobile units.
  
  

Leading Market Players

Key companies in the mobile gamma camera market include firms specialising in nuclear-imaging equipment and portable diagnostic devices. These companies focus on product innovation (lighter, faster, higher resolution systems), service/support networks, and expanding geographic reach.

Recent Industry Developments

• Launches of new mobile gamma camera systems with improved acquisition speed, compact size, and improved workflow integration.
  
  
• Increased interest in deploying mobile imaging solutions in outpatient settings, imaging centres, and remote/bedside applications.
  
  
• Growth in strategic partnerships between equipment manufacturers and healthcare providers/academics to validate mobile gamma cameras in new clinical settings.
  
  
• Expansion into emerging markets with incremental adoption of mobile imaging to address equipment constraints and patient mobility issues.
  
  

Conclusion

The mobile gamma cameras market is positioned for steady growth, supported by demand for portable diagnostic imaging, technological innovation in mobile systems and expansion of healthcare infrastructure globally. Suppliers that emphasise cost-efficient, high-performance portable systems, strong service/support networks and tailored solutions for emerging markets are well-placed to capitalise on this trend. While challenges around cost, reimbursement and clinical integration remain, the overall outlook is positive for this diagnostic-imaging niche.